Telemetry Investments, L.L.C. Immuno Gen, Inc. Call Options Transaction History

Telemetry Investments, L.L.C.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2019 May 15, 2019	SELL	$2.41 - $5.91 $60,250 - $147,750	-25,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$3.94 - $9.7 $98,500 - $242,499	-25,000 Reduced 50.0%	25,000 $120,000
Q3 2018 Nov 14, 2018	BUY	$8.6 - $11.26 $430,000 - $563,000	50,000 New	50,000 $474,000
Q1 2018 May 15, 2018	SELL	$6.7 - $12.95 $1.82 Million - $3.52 Million	-272,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$5.07 - $7.92 $770,640 - $1.2 Million	152,000 Added 126.67%	272,000 $1.74 Million
Q3 2017 Nov 14, 2017	BUY	$5.4 - $8.47 $648,000 - $1.02 Million	120,000	120,000 $918,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Telemetry Investments, L.L.C. with notifications on news.